PH vs PTHS · P/E 28, rev $19.85B vs rev $7.4M
Parker-Hannifin Corporation (PH) versus Pelthos Therapeutics Inc. (PTHS) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Latest reported PTHS revenue for 2025-09-30 was $7.4M. Net income was -$16.2M. PTHS currently screens at market cap $94.7M.
PH currently screens at market cap $91.89B and trailing P/E 27.7. PTHS currently screens at market cap $94.7M.
Not investment advice. Open the PH and PTHS stock pages for the full models.
Not investment advice.